Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marta Torrens

Showing results (131-140 of 197) with videos related to

Pageof 20
Sort By:
Neurology and Therapy|January 6, 2025
Efficacy of Lurasidone in First-Episode Psychosis: Patient Phenotypes, Dosage, and Recommendations from an Expert PanelMiquel Bernardo, Marina Díaz Marsá, Ana González-Pinto, et al.
Adicciones|February 8, 2017
Patients with alcohol use disorder: initial results from a prospective multicenter registry in the Spanish Network on Addiction Disorders. CohRTA StudyArantza Sanvisens, Paola Zuluaga, Inmaculada Rivas, et al.
Biology|May 28, 2022
New Psychoactive Substances Consumption in Opioid-Use Disorder PatientsMaria Alías-Ferri, Manuela Pellegrini, Emilia Marchei, et al.
Frontiers in Psychiatry|August 22, 2022
Synthetic cannabinoids use in a sample of opioid-use disorder patientsMaría Alías-Ferri, Manuela Pellegrini, Emilia Marchei, et al.
Frontiers in Psychiatry|May 17, 2021
Non-medical Use of Prescription Gabapentinoids (Gabapentin and Pregabalin) in Five European CountriesFrancina Fonseca, William Lenahan, Richard C Dart, et al.
Lancet (London, England)|November 1, 2019
Responding to global stimulant use: challenges and opportunitiesMichael Farrell, Natasha K Martin, Emily Stockings, et al.
Frontiers in Psychiatry|November 15, 2021
Developing an App to Screen for Dual Disorders: A Tool for Improving Treatment Services in MexicoRodrigo Marín-Navarrete, Marta Torrens, Aldebarán Toledo-Fernández, et al.
Adicciones|February 27, 2020
Cocaine and depressive disorders: When standard clinical diagnosis is insufficientMaria Alías-Ferri, Nuria García-Marchena, Joan Ignasi Mestre-Pintó, et al.
Plos One|November 1, 2012
Clinical pharmacology of 3,4-methylenedioxymethamphetamine (MDMA, "ecstasy"): the influence of gender and genetics (CYP2D6, COMT, 5-HTT)Ricardo Pardo-Lozano, Magí Farré, Samanta Yubero-Lahoz, et al.
European Psychiatry : the Journal of the Association of European Psychiatrists|December 26, 2006
Diagnostic Interview for Genetic Studies (DIGS): inter-rater and test-retest reliability and validity in a Spanish populationMiguel Roca, Rocio Martin-Santos, Jerónimo Saiz, et al.
Pageof 20

Showing results (131-140 of 197) with videos related to

Sort By:
Pageof 20
Neurology and Therapy|January 6, 2025
Efficacy of Lurasidone in First-Episode Psychosis: Patient Phenotypes, Dosage, and Recommendations from an Expert PanelMiquel Bernardo, Marina Díaz Marsá, Ana González-Pinto, et al.
Adicciones|February 8, 2017
Patients with alcohol use disorder: initial results from a prospective multicenter registry in the Spanish Network on Addiction Disorders. CohRTA StudyArantza Sanvisens, Paola Zuluaga, Inmaculada Rivas, et al.
Biology|May 28, 2022
New Psychoactive Substances Consumption in Opioid-Use Disorder PatientsMaria Alías-Ferri, Manuela Pellegrini, Emilia Marchei, et al.
Frontiers in Psychiatry|August 22, 2022
Synthetic cannabinoids use in a sample of opioid-use disorder patientsMaría Alías-Ferri, Manuela Pellegrini, Emilia Marchei, et al.
Frontiers in Psychiatry|May 17, 2021
Non-medical Use of Prescription Gabapentinoids (Gabapentin and Pregabalin) in Five European CountriesFrancina Fonseca, William Lenahan, Richard C Dart, et al.
Lancet (London, England)|November 1, 2019
Responding to global stimulant use: challenges and opportunitiesMichael Farrell, Natasha K Martin, Emily Stockings, et al.
Frontiers in Psychiatry|November 15, 2021
Developing an App to Screen for Dual Disorders: A Tool for Improving Treatment Services in MexicoRodrigo Marín-Navarrete, Marta Torrens, Aldebarán Toledo-Fernández, et al.
Adicciones|February 27, 2020
Cocaine and depressive disorders: When standard clinical diagnosis is insufficientMaria Alías-Ferri, Nuria García-Marchena, Joan Ignasi Mestre-Pintó, et al.
Plos One|November 1, 2012
Clinical pharmacology of 3,4-methylenedioxymethamphetamine (MDMA, "ecstasy"): the influence of gender and genetics (CYP2D6, COMT, 5-HTT)Ricardo Pardo-Lozano, Magí Farré, Samanta Yubero-Lahoz, et al.
European Psychiatry : the Journal of the Association of European Psychiatrists|December 26, 2006
Diagnostic Interview for Genetic Studies (DIGS): inter-rater and test-retest reliability and validity in a Spanish populationMiguel Roca, Rocio Martin-Santos, Jerónimo Saiz, et al.
Pageof 20